4-methyl-2-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)aniline, 95.0%, 5g

1-(2-ethylphenyl)-5-oxopyrrolidine-3-carboxylic acid, 95.0%, 2.5g

3-Chloro-6-fluoroisoquinoline, 95.0%, 1g

(S)-tert-Butyl 2-(1H-imidazol-2-yl)pyrrolidine-1-carboxylate, 95.0%, 25g

TERT-BUTYL 4-(6-BROMO-3,4-DIHYDROQUINOLIN-1(2H)-YL)PIPERIDIN-1-CARBOXYLATE, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 1,00 µm, 1 Stück

(4-Chloro-6-methyl-pyrimidin-2-yl)-methyl-amine, 95.0%, 5g

4-(4-(Trifluoromethyl)phenyl)-1H-imidazole, 97.0%, 1g

2,5-Norbornadiene, 98.0%, 10g

2-Methyl-2H-pyrazol-3-ylamine, 98.0%, 1g

4-((TERT-BUTYLDIPHENYLSILYL)OXY)-2,2-DIMETHYLBUTAN-1-OL, 95.0%, 500mg

N,N-Dimethyl-4-nitroaniline>98.0%(GC)(T)5g

(2E)-1-(2,4-dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g